Gryphon Financial Partners LLC Sells 676 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Gryphon Financial Partners LLC lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 54.1% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 574 shares of the medical equipment provider’s stock after selling 676 shares during the quarter. Gryphon Financial Partners LLC’s holdings in Intuitive Surgical were worth $300,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. M.E. Allison & CO. Inc. acquired a new position in Intuitive Surgical during the fourth quarter valued at approximately $449,000. Seilern Investment Management Ltd acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $82,517,000. Sycomore Asset Management increased its position in shares of Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after buying an additional 4,079 shares in the last quarter. Exome Asset Management LLC raised its stake in Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after buying an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. lifted its holdings in Intuitive Surgical by 5.6% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after acquiring an additional 525 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $566.98 on Tuesday. The stock has a market cap of $201.95 billion, a P/E ratio of 88.45, a P/E/G ratio of 5.85 and a beta of 1.39. The company has a fifty day moving average price of $570.66 and a two-hundred day moving average price of $530.08. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the company. Citigroup increased their price target on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Barclays raised their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Bernstein Bank upped their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a report on Monday, January 27th. Piper Sandler reissued an “overweight” rating and set a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Finally, BTIG Research boosted their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. One analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Insider Activity at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 270 shares of the firm’s stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,730,093.55. This represents a 2.99 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 12,598 shares of company stock worth $7,223,467. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.